Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Why Major Funds Are Betting Big on Clean Harbors Stock

Dieter Jaworski by Dieter Jaworski
September 9, 2025
in Analysis, Industrial, Insider Trading
0
Clean Harbors Stock
0
SHARES
154
VIEWS
Share on FacebookShare on Twitter

While many individual investors remain cautious amid recent market turbulence, institutional players appear to be identifying significant opportunity in Clean Harbors. Substantial position increases by major fund managers and a notable vote of confidence from the company’s CEO suggest untapped potential within the environmental services sector. What exactly are these professional investors seeing in this specialized company?

Strong Institutional Accumulation

The actions of major investment firms provide a compelling narrative. Adage Capital Partners significantly boosted its stake by acquiring 130,000 additional shares during the first quarter, bringing its total holdings to a value of $44.74 million. In an even more assertive move, Boothbay Fund Management expanded its position by 37.8 percent. This substantial buying activity from sophisticated institutions sends a clear message: these investors are focused on long-term value creation rather than short-term market fluctuations.

Management Confidence Through Personal Investment

Perhaps the most powerful indicator of internal confidence comes from the top. In early August, CEO Michael Louis Battles personally increased his stake by acquiring 2,000 additional shares at a price of $233.50 per share. This direct purchase, as opposed to simply exercising stock options, typically signals a genuine belief in the company’s intrinsic value and future prospects from its leadership.

Analyst Consensus Points to Upside

The confidence extends to Wall Street research firms. Market experts have been issuing bullish recommendations, with Truist Financial recently reaffirming its Buy rating. Raymond James took an even more optimistic stance, raising its price target to $280 per share. The current analyst consensus price target sits at $263.40, indicating a general expectation for further appreciation. These assessments are grounded in the company’s solid fundamental performance rather than speculative optimism.

Should investors sell immediately? Or is it worth buying Clean Harbors?

Resilient Quarterly Performance

Clean Harbors delivered a mixed but fundamentally robust set of second-quarter results. The company reported earnings per share (EPS) of $2.36, surpassing analyst expectations. Although revenue of $1.55 billion slightly missed forecasts, strength was particularly evident in the Environmental Services segment, where adjusted EBITDA climbed 4.5 percent to reach $376 million. Strategic price increases helped drive revenue for Safety-Kleen Environmental Services upward by 9 percent.

The company did face headwinds in its Safety-Kleen Sustainability Solutions division, where weaker base oil market conditions contributed to a 25.6 percent decline in EBITDA. Despite this segment-specific challenge, management reaffirmed its full-year guidance, demonstrating confidence in its overall business strategy and the company’s ability to navigate different market cycles.

The combination of strong institutional accumulation, insider buying, positive analyst sentiment, and resilient operational performance creates a compelling case for Clean Harbors. While not every business unit is firing on all cylinders, the overarching indicators suggest that professional investors have identified a company positioned for long-term success.

Ad

Clean Harbors Stock: Buy or Sell?! New Clean Harbors Analysis from February 7 delivers the answer:

The latest Clean Harbors figures speak for themselves: Urgent action needed for Clean Harbors investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Clean Harbors: Buy or sell? Read more here...

Tags: Clean Harbors
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Next Post
Cardiff Oncology Stock

Cardiff Oncology Maintains Busy Investor Outreach Schedule

Micron Stock

Micron Stock Surges on AI Demand as Investors Eye Critical Earnings

Adobe Stock

Adobe's AI Strategy Faces Critical Investor Test

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com